Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWXSX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $117,392
Award facts
- Contract value 100% obligated
- $117,392.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xeljanz XR 11 mg tablets in quantities of 30-count units, with a contract ceiling value of $117,392.05. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, with an ultimate completion date of June 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a prime contractor under the DLA Troop Support Medical umbrella, the company maintains an extensive portfolio of federal contract awards for brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal procurement requirements through competitive processes, combined with its significant IDC vehicle, positions it as a key supplier for pharmaceutical needs within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FWXSX?
SPE2DB25FWXSX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FWXSX worth?
The government has obligated $117,392 on SPE2DB25FWXSX.
Is contract SPE2DB25FWXSX an order under another contract?
Yes. SPE2DB25FWXSX is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWXSX competed?
The extent of competition for SPE2DB25FWXSX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award